165 related articles for article (PubMed ID: 27252091)
1. The diagnostic and prognostic value of SALL4 in hepatoblastoma.
Zhou S; Venkatramani R; Gomulia E; Shillingford N; Wang L
Histopathology; 2016 Nov; 69(5):822-830. PubMed ID: 27252091
[TBL] [Abstract][Full Text] [Related]
2. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
3. SALL4 is a marker of the embryonal subtype of hepatoblastoma.
Gnemmi V; Leteurtre E; Sudour-Bonnange H; Devisme L; Guettier C; Buob D; Leroy X
Histopathology; 2013 Sep; 63(3):425-8. PubMed ID: 23822878
[TBL] [Abstract][Full Text] [Related]
4. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
5. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
6. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
Yin F; Han X; Yao SK; Wang XL; Yang HC
World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
[TBL] [Abstract][Full Text] [Related]
7. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
[TBL] [Abstract][Full Text] [Related]
8. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
9. Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma.
Huang WJ; Tsai JH; Jeng YM
J Formos Med Assoc; 2017 Jul; 116(7):549-553. PubMed ID: 28277286
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.
Qiao GL; Li L; Cheng W; Ge J; Zhang Z; Wei Y
Eur J Surg Oncol; 2014 Nov; 40(11):1533-9. PubMed ID: 25103357
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
13. The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis.
Azukisawa S; Zheng J; Guo X; Ura H; Niida Y; Itoh T; Yamada S
Histol Histopathol; 2021 Nov; 36(11):1169-1178. PubMed ID: 34477212
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma.
Saida S; Watanabe K; Kato I; Fujino H; Umeda K; Okamoto S; Uemoto S; Hishiki T; Yoshida H; Tanaka S; Adachi S; Niwa A; Nakahata T; Heike T
Pediatr Int; 2015 Aug; 57(4):558-66. PubMed ID: 25682862
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of hedgehog signal component expressions in hepatoblastoma patients.
Li YC; Deng YH; Guo ZH; Zhang MM; Zhu J; Pu CL; Xiang CP; Guo CB
Eur J Med Res; 2010 Nov; 15(11):468-74. PubMed ID: 21159571
[TBL] [Abstract][Full Text] [Related]
16. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.
Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888
[TBL] [Abstract][Full Text] [Related]
17. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
[TBL] [Abstract][Full Text] [Related]
18. SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.
Liu TC; Vachharajani N; Chapman WC; Brunt EM
Am J Surg Pathol; 2014 Jul; 38(7):966-72. PubMed ID: 24805857
[TBL] [Abstract][Full Text] [Related]
19. High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.
Weiss JBW; Wagner AE; Eberherr C; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
Cancer Biomark; 2020; 28(3):321-328. PubMed ID: 32390604
[TBL] [Abstract][Full Text] [Related]
20. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]